Effect of methylphenidate on oculomotor function in individuals with multiple sclerosis: a pilot randomized placebo-controlled trial.

Front Neurol · 2024 · PMC11153819 · PMID 38846035

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

marginally significantp = 0.053so close (0.05 < p ≤ 0.1)

We found significant differences for the PASAT [ F (2,18) = 5.77, p = 0.012] with a post hoc pairwise comparison using the Bonferroni correction showing a marginally significant improvement in PASAT scores in the methylphenidate condition as compared to the baseline condition (43.7 ± 4.0 vs. 38.7 ± 4.9, respectively, p = 0.053).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.